HSA Singapore: Adverse Effects from Banned Medicinal Products
Summary
HSA Singapore has issued a notice regarding adverse effects reported after consumers took banned medicinal products. The agency is highlighting the risks associated with using unapproved health products and urges consumers to exercise caution.
What changed
The Health Sciences Authority (HSA) of Singapore has released a notice detailing adverse effects experienced by consumers who ingested banned medicinal products. This announcement serves to alert the public and healthcare professionals about the potential dangers of unapproved health products, emphasizing that these products have not undergone safety and quality evaluations by HSA and may contain potent ingredients or undeclared Western medicines.
Consumers are strongly advised to cease using any banned medicinal products and to consult a doctor if they experience adverse effects. Healthcare providers are encouraged to be vigilant and report any suspected adverse reactions linked to such products. The notice underscores the importance of relying on legitimate and approved health products to ensure personal safety and well-being.
What to do next
- Consumers should cease use of banned medicinal products and consult a doctor if experiencing adverse effects.
- Healthcare providers should remain vigilant for adverse effects potentially linked to banned products and report them to HSA.
Source document (simplified)
Press Releases
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when HSA Singapore Announcements publishes new changes.